Oncologist-led germline genetic testing for uveal melanoma.

Brittany GilliesHatem KremaAnning ChaoLeonardo LandoKirsten M FarncombeMarcus ButlerFiliberto AltomareRaymond H Kim

Published in: Ophthalmic genetics (2023)

mutation was detected in 3.5% of unselected UM patients. The oncologist-initiated and genetics-led mainstreaming model is a straightforward process and can be utilized for offering genetic testing to all UM patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
oxidative stress
patient reported outcomes